244 related articles for article (PubMed ID: 8310940)
1. Visualization of blood-brain barrier disruption on MR images of cats with acute cerebral infarction: value of administering a high dose of contrast material.
Runge VM; Kirsch JE; Wells JW; Dunworth JN; Woolfolk CE
AJR Am J Roentgenol; 1994 Feb; 162(2):431-5. PubMed ID: 8310940
[TBL] [Abstract][Full Text] [Related]
2. Assessment of cerebral perfusion by first-pass, dynamic, contrast-enhanced, steady-state free-precession MR imaging: an animal study.
Runge VM; Kirsch JE; Wells JW; Woolfolk CE
AJR Am J Roentgenol; 1993 Mar; 160(3):593-600. PubMed ID: 8430562
[TBL] [Abstract][Full Text] [Related]
3. MR imaging of acute cerebral infarction: experimental study with Gd-DTPA.
Hayakawa K; Yamashita K; Matsuda T; Miyake T; Ito H
Radiat Med; 1989; 7(2):58-65. PubMed ID: 2798931
[TBL] [Abstract][Full Text] [Related]
4. [Brain magnetic resonance with magnetization transfer in multiple sclerosis. Lesion hyperintensity before and after intravenous gadolinium administration].
Renzetti P; Parodi RC; Losacco C; Rosso E; Arcuri T; Sardanelli F
Radiol Med; 1999 Sep; 98(3):138-43. PubMed ID: 10575442
[TBL] [Abstract][Full Text] [Related]
5. Magnetic resonance evaluation of brain metastases from systemic malignances with two doses of gadobutrol 1.0 m compared with gadoteridol: a multicenter, phase ii/iii study in patients with known or suspected brain metastases.
Katakami N; Inaba Y; Sugata S; Tsurusaki M; Itoh T; Machida T; Tanaka H; Nakayama T; Morikawa T; Breuer J; Aitoku Y
Invest Radiol; 2011 Jul; 46(7):411-8. PubMed ID: 21467949
[TBL] [Abstract][Full Text] [Related]
6. MR imaging of the myocardium using nonionic contrast medium: signal-intensity changes in patients with subacute myocardial infarction.
Dulce MC; Duerinckx AJ; Hartiala J; Caputo GR; O'Sullivan M; Cheitlin MD; Higgins CB
AJR Am J Roentgenol; 1993 May; 160(5):963-70. PubMed ID: 8470611
[TBL] [Abstract][Full Text] [Related]
7. Cerebral infarction: effects of dose and magnetization transfer saturation at gadolinium-enhanced MR imaging.
Mathews VP; King JC; Elster AD; Hamilton CA
Radiology; 1994 Feb; 190(2):547-52. PubMed ID: 8284414
[TBL] [Abstract][Full Text] [Related]
8. Phase II clinical trial of gadoteridol injection, a low-osmolal magnetic resonance imaging contrast agent.
Carvlin MJ; De Simone DN; Meeks MJ
Invest Radiol; 1992 Aug; 27 Suppl 1():S16-21. PubMed ID: 1506148
[TBL] [Abstract][Full Text] [Related]
9. Gadoteridol-enhanced MR imaging of malignant hepatic tumors: effects of triple versus standard doses on lesion-liver contrast.
Petersein J; Saini S; Mitchell DG; Davis PL; Johnson CD; Kuhlman JE; Parisky YR; Runge VM; Weinreb J; Bernardino ME
AJR Am J Roentgenol; 1995 Nov; 165(5):1157-61. PubMed ID: 7572495
[TBL] [Abstract][Full Text] [Related]
10. Contrast-enhanced MR angiography for the diagnosis of intracranial vascular disease: optimal dose of gadopentetate dimeglumine.
Jung HW; Chang KH; Choi DS; Han MH; Han MC
AJR Am J Roentgenol; 1995 Nov; 165(5):1251-5. PubMed ID: 7572513
[TBL] [Abstract][Full Text] [Related]
11. MR arthrography of the shoulder with gadopentetate dimeglumine: influence of concentration, iodinated contrast material, and time on signal intensity.
Kopka L; Funke M; Fischer U; Keating D; Oestmann J; Grabbe E
AJR Am J Roentgenol; 1994 Sep; 163(3):621-3. PubMed ID: 8079856
[TBL] [Abstract][Full Text] [Related]
12. [Diagnosis of cerebral metastasis with standard dose gadobutrol vs. a high dose protocol. Intraindividual evaluation of a phase II high dose study].
Vogl TJ; Friebe CE; Balzer T; Mack MG; Steiner S; Schedel H; Pegios W; Lanksch W; Banzer D; Felix R
Radiologe; 1995 Aug; 35(8):508-16. PubMed ID: 7568795
[TBL] [Abstract][Full Text] [Related]
13. MR imaging of reperfused myocardial infarction: comparison of necrosis-specific and intravascular contrast agents in a cat model.
Lee SS; Goo HW; Park SB; Lim CH; Gong G; Seo JB; Lim TH
Radiology; 2003 Mar; 226(3):739-47. PubMed ID: 12601203
[TBL] [Abstract][Full Text] [Related]
14. Update: safety, new applications, new MR agents.
Runge VM; Wells JW
Top Magn Reson Imaging; 1995; 7(3):181-95. PubMed ID: 7654396
[TBL] [Abstract][Full Text] [Related]
15. Half-dose gadolinium-enhanced MR imaging with magnetization transfer technique in brain tumors: comparison with conventional contrast-enhanced MR imaging.
Han D; Chang KH; Han MH; Cho JY; Han SW; Kim HD; Seong SO
AJR Am J Roentgenol; 1998 Jan; 170(1):189-93. PubMed ID: 9423630
[TBL] [Abstract][Full Text] [Related]
16. High-dose applications of gadolinium chelates in magnetic resonance imaging.
Runge VM; Kirsch JE; Thomas GS
Magn Reson Med; 1991 Dec; 22(2):358-63. PubMed ID: 1812371
[TBL] [Abstract][Full Text] [Related]
17. Brain tumor enhancement in magnetic resonance imaging at 3 tesla: intraindividual comparison of two high relaxivity macromolecular contrast media with a standard extracellular gd-chelate in a rat brain tumor model.
Fries P; Runge VM; Bücker A; Schürholz H; Reith W; Robert P; Jackson C; Lanz T; Schneider G
Invest Radiol; 2009 Apr; 44(4):200-6. PubMed ID: 19300099
[TBL] [Abstract][Full Text] [Related]
18. Acute stroke in cats: comparison of dynamic susceptibility-contrast MR imaging with T2- and diffusion-weighted MR imaging.
Maeda M; Itoh S; Ide H; Matsuda T; Kobayashi H; Kubota T; Ishii Y
Radiology; 1993 Oct; 189(1):227-32. PubMed ID: 8372198
[TBL] [Abstract][Full Text] [Related]
19. Sensitivity of immediate and delayed gadolinium-enhanced MRI after injection of 0.5 M and 1.0 M gadolinium chelates for detecting multiple sclerosis lesions.
Uysal E; Erturk SM; Yildirim H; Seleker F; Basak M
AJR Am J Roentgenol; 2007 Mar; 188(3):697-702. PubMed ID: 17312056
[TBL] [Abstract][Full Text] [Related]
20. [Contrast-enhanced MR imaging using double doses of gadolinium-DTPA in evaluating brain and spinal diseases].
Matsumoto S; Hasuo K; Uchino A; Matsuura Y; Gibo M; Fukui M; Masuda K
Nihon Igaku Hoshasen Gakkai Zasshi; 1993 May; 53(5):503-10. PubMed ID: 8327315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
